|
|
|
Insider
Information: |
Bronfeld Zeev |
Relationship: |
10% Owner |
City: |
Tel Aviv |
State: |
L3 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
11,871,004 |
|
Indirect Shares
|
42,781,250 |
|
|
Direct
Value |
$14,570,718 |
|
|
Indirect Value
|
$1,882,813 |
|
|
Total
Shares |
54,652,254 |
|
|
Total
Value |
$16,453,531 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gammacan International Inc |
GCAN |
10% Owner |
2004-07-19 |
3,900,006 |
|
0 |
Premium* |
|
Oramed Pharmaceuticals Inc |
ORMP |
10% Owner |
2011-09-27 |
5,808,517 |
2011-09-27 |
781,250 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director |
2014-10-02 |
2,162,481 |
2014-10-02 |
0 |
Premium* |
|
Global Energy Inc |
GEYI |
10% Owner |
2007-04-30 |
0 |
2007-04-30 |
42,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEYI |
Global Energy Inc |
10% Owner |
|
2007-04-30 |
4 |
B |
$0.01 |
$300,000 |
I/I |
30,000,000 |
42,000,000 |
1.5 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2006-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
14,466,319 |
14,466,319 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2014-09-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,556,371) |
1,509,948 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2014-08-13 |
4 |
S |
$2.47 |
$10,868,000 |
I/I |
(4,400,000) |
10,066,319 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2014-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,838,109 |
1,838,109 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2014-10-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,509,948) |
0 |
0 |
- |
|
ORMP |
Oramed Pharmaceuticals In... |
10% Owner |
|
2011-03-31 |
4 |
B |
$0.32 |
$250,000 |
I/I |
781,250 |
7,213,205 |
1.5 |
- |
|
ORMP |
Oramed Pharmaceuticals In... |
10% Owner |
|
2011-09-27 |
4 |
S |
$0.28 |
$98,000 |
D/D |
(350,000) |
5,808,517 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2014-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
324,372 |
2,162,481 |
0 |
- |
|
GCAN |
Gammacan International In... |
10% Owner |
|
2004-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,900,006 |
|
- |
|
ORMP |
Oramed Pharmaceuticals In... |
10% Owner |
|
2006-02-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,158,517 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|